Independent Pharmacies Must Expand Services to Stay Afloat | AAP 2025
Drug Topics
APRIL 16, 2025
At AAP 2025, Douglas Hoey, RPh, MBA, CEO of NCPA, discussed what pharmacies can do to increase revenue and avoid shutting their doors.
Wed.Apr 16, 2025
465 
Amid an onshoring push, Raleigh is poised to be pharma’s next manufacturing hub
PharmaVoice
APRIL 16, 2025
Lower operating costs and a supply of high-skilled workers are helping the North Carolina region pull in billions of pharma manufacturing investments.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
FDA Approves Diazepam Nasal Spray for Treatment of Seizure Clusters in Pediatric Patients
Drug Topics
APRIL 16, 2025
The drug is approved for the short-term treatment of acute repetitive seizures, also known as seizure clusters, which differ from a patients normal seizure pattern.
What is Data-Driven Marketing in Pharma
Pharma Marketing Network
APRIL 16, 2025
Imagine launching a brand campaign without guessworkwhere your message reaches the right healthcare professional at the right time on the right channel. Thats the promise of data-driven marketing , a strategy thats rapidly transforming how pharmaceutical companies approach promotion, education, and engagement in 2025. As privacy regulations evolve, customer expectations change, and AI-driven technologies emerge, pharma marketers must adapt or risk becoming irrelevant.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Skin of Color Dermatology Substantially Improved in Last 20 Years
Drug Topics
APRIL 16, 2025
Over 20 years since skin of color dermatology was introduced, researchers explored advancements and what is yet to come in the future.
COVID-19 Associated With Higher Risk of Postacute Kidney Outcomes in Pediatric Patients With Preexisting CKD
Pharmacy Times
APRIL 16, 2025
At 28 to 179 days, COVID-19 infection in patients with preexisting chronic kidney disease (CKD) was associated with an increased risk of composite kidney events.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Diazepam Nasal Spray Receives FDA Approval for Seizure Clusters in Individuals 2 Years and Older
Pharmacy Times
APRIL 16, 2025
The safety profile of diazepam nasal spray among pediatric patients was consistent with older patients, supporting its use in this age group.
Pharmacist Counseling ‘Paramount’ in Use of OTC Pain Medications
Drug Topics
APRIL 16, 2025
Pain expert Mark Garofoli, PharmD, BCGP, CPE, CTTS, discussed the pharmacists role in managing patients use of OTC pain relief products.
Content Marketing Strategies Used in Pharma Marketing
Pharma Marketing Network
APRIL 16, 2025
If your brand still views content as a checkbox for SEO or a static digital asset, you’re already falling behind. In the ever-evolving healthcare landscape, especially in 2025, content marketing strategies have moved from optional to mission-critical for pharma brands. But not just any content will do. Today, successful campaigns are dynamic, identity-driven, omnichannel, and personalized.
More Than Just Meds: What a Palliative Care Pharmacist Learned From the Bedside
Pharmacy Times
APRIL 16, 2025
A palliative care pharmacist highlights a spectrum of clinical opportunities for patients, caregivers, and clinicians when rounding at the bedside.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Enforcement Under the New FDA: HPM to Host a Q&A Webinar on FDC Act Enforcement with Three Former Federal Prosecutors
The FDA Law Blog
APRIL 16, 2025
By Andrew J. Hull & JP Ellison & John W.M. Claud Hyman, Phelps & McNamara, P.C. is hosting a free webinar on recent and forward-looking enforcement under the Federal Food, Drug & Cosmetic Act on Thursday, May 1, 2025, from 12:00 p.m. to 1:30 p.m. (ET) (register here ). Join us as HPMs Anne Walsh moderates a panel discussion with three former DOJ attorneys who all litigated extensively under the FDCA.
Streamlining JCA Response with GenAI
pharmaphorum
APRIL 16, 2025
The Joint Clinical Assessment (JCA) framework took effect on 12th January 2025, and its impact is top of mind among pharma innovators today.
The Tech Truth: Stepping Up as Pharmacy Technician Leaders
Pharmacy Times
APRIL 16, 2025
Pharmacy technicians have a pivotal opportunity to advance professionally by proactively demonstrating leadership, offering solutions, and clearly communicating their value to health care leaders.
FDA clears first migraine DTx from Click Therapeutics
pharmaphorum
APRIL 16, 2025
Click Therapeutics' digital therapeutic (DTx) for migraine prevention has been cleared by the FDA, becoming the first treatment of its type in the US.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Five Domains, One Outcome: How Social Factors Shape Cancer Survival
Pharmacy Times
APRIL 16, 2025
Iman Ahmed, PharmD, BCOP shared key insights about how social determinants of health impact treatment access and outcomes for patients with leukemia.
UK Biobank responds to fears over Chinese access to NHS data
pharmaphorum
APRIL 16, 2025
Access to de-identified NHS patient data by researchers based in China is not a security concern, according to UK Biobank.
APA, NCPA Cheer First-Of-Its-Kind State Law Banning PBMs from Owning Pharmacies
Pharmacy Times
APRIL 16, 2025
Arkansas HB 1150 a model for other states, federal government, organizations say.
WHO member states agree on treaty to fight future pandemics
Pharmaceutical Technology
APRIL 16, 2025
The agreement is seen as a win for global health ahead of the US withdrawal from the WHO and amidst foreign aid cuts by the US government.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Inhaled siRNA-Based MIR 19 Reduces Progression to Severe Disease in Outpatients With Mild COVID-19
Pharmacy Times
APRIL 16, 2025
With a more direct mechanism of action against viral replication compared with standard treatments, the small interfering RNA (siRNA)-based MIR 19 treatment could revolutionize outpatient COVID-19 treatment.
Fierce Healthcare - Untitled Article
Fierce Healthcare
APRIL 16, 2025
VC firm SignalFire closed on $1 billion in new capital to fund applied AI companies; a handful of health systems backed Hellocare.ai's funding round and Layer Health picked up $21 million in series A funding to scale its AI-powered platform.
Innovations in Hematology and Oncology Explored at HOPA Annual Conference
Pharmacy Times
APRIL 16, 2025
Zahra Mahmoudjafari, PharmD, BCOP, FHOPA, shared insight from the HOPA Annual Meeting 2025.
Fierce Healthcare - Untitled Article
Fierce Healthcare
APRIL 16, 2025
The deal for Cedar Park Regional Medical Center and other ancillary businesses is expected to close this summer. Ascension Seton already held a minority interest in the hospital, and said that sole ownership will allow for service expansions.
Ten Years of Telemedicine- Based Prescribing Leads to Lawsuit
Pharmacy Times
APRIL 16, 2025
Pharmacy and physician were defendants.
Fierce Healthcare - Untitled Article
Fierce Healthcare
APRIL 16, 2025
In a new report, the group says CMS should pay more for conditions that respond better to the technology, like hypertension. It cautions against broad use of the technology for diabetes.
Allogenic T Regulatory Cell Product CK0801 Granted FDA Orphan Drug Designation for Aplastic Anemia Treatment
Pharmacy Times
APRIL 16, 2025
Some patients with aplastic anemia treated with CK0801 achieved durable transfusion independence lasting over 3 years.
The potential of digital health and AI for transforming rare disease care
pharmaphorum
APRIL 16, 2025
Discover the transformative potential of digital health and AI in providing cutting-edge care for rare diseases like Lysosomal Storage Disorders (LSDs). Learn about the latest advancements and innovations in rare disease management and early diagnosis.
Essential Immune Cells in Intestine Causes Gut Inflammation, Allergic Responses to Foods When Absent
Pharmacy Times
APRIL 16, 2025
In mouse models, researchers identified that immune cells within the intestine may prevent unwarranted attacks against harmless food allergens.
Fierce Healthcare - Untitled Article
Fierce Healthcare
APRIL 16, 2025
This week on "Podnosis," Fierce Healthcare Senior Writer Anastassia Gliadkovskaya talks with Equips Jessie Menzel, Ph.D., about gaps in eating disorder care.
Reduced POMP Dosing Shows Comparable Efficacy in ALL Maintenance
Pharmacy Times
APRIL 16, 2025
Arefa Bacchus, PharmD shared key insights about the use of POMP therapy in patients with acute lymphoblastic leukemia (ALL).
Fierce Healthcare - Untitled Article
Fierce Healthcare
APRIL 16, 2025
Investment returns are a key component of nonprofit hospitals' financial resiliency. Recent tariff-fueled shocks to the market may leave these hospitals less prepared to fend off higher supply costs and other operating headwinds, Fitch Ratings warned this week.
Diazepam Nasal Spray Receives FDA Approval for Seizure Clusters in Individuals Aged 2 Years and Older
Pharmacy Times
APRIL 16, 2025
The safety profile of diazepam nasal spray among pediatric patients was consistent with older patients, supporting its use in this age group.
LogiPharma Europe 2025: Pharma Leaders Prioritize Artificial Intelligence and Sustainability
Pharmaceutical Commerce
APRIL 16, 2025
Will Robinson, program director, LogiPharma, explains how artificial intelligence and sustainability are driving a clear shift in priorities across the pharmaceutical supply chain.
Improving Your Earned Media Strategy: Tips and Insights
PharmExec
APRIL 16, 2025
Introducing a new series highlighting ways pharma companies can up their game in winning earned mediaand ultimately deliver greater impact and value from their messaging.
Let's personalize your content